✦ Launching soon. Save the pens you want and we'll email you the moment they're available.
Veyvora

By Veyvora Research · Updated August 2026

What HPLC Purity Does and Does Not Prove | Veyvora

Overview

HPLC (High-Performance Liquid Chromatography) purity is a relative chromatographic measurement: the reported percentage is the target peak area divided by the total measured peak area under the stated method conditions. The result describes how detector response is distributed among the separated components; the amount of compound in the vial is reported by the assay, and the identity of the main peak by mass spectrometry. A result of 99% means that 99% of the detector response belongs to the main peak.

What does HPLC purity mean? Chromatographic purity is one of several results on a certificate; identity, absolute content, sterility and endotoxin status each have their own method. ICH Q2(R2) (2023) separates purity and impurity testing from identity procedures and assay procedures, noting that different analytical methods may be required when a single procedure cannot provide sufficient discrimination [1]. USP ⟨621⟩ frames chromatography as a separation technique whose output depends on system suitability and defined method conditions; the figure is valid within the validated reportable range of that specific method [2].

That method-dependence is the detail to keep in view in batch acceptance. A high area-percentage result reports that few chromatographically separated impurities were detected under those conditions; impurities that fall outside the method’s selectivity or detector response range are characterised by orthogonal methods [1].

HPLC Purity: Analytical Purpose

HPLC purity is a method-specific estimate of detected-component distribution: the reported percentage is the target peak area divided by the total measured peak area under the stated method conditions. ICH Q2(R2) (2023) defines the purpose of a purity procedure as demonstrating that the method is fit for its intended use, specifically that the method can separate the analyte from impurities or related substances without relevant interference [1]. USP ⟨621⟩ frames chromatography as a separation technique whose output is meaningful within the validated reportable range of the specific method applied [2].

That method-dependence has direct consequences for batch acceptance. A result of 99% area purity confirms that 99% of the detector response belongs to the main peak under those conditions; the identity of that peak, the mass of compound present and any impurities outside the method’s selectivity range are reported by the identity, assay and orthogonal impurity procedures [1].

ICH Q2(R2) (2023) explicitly separates purity and impurity testing from identity procedures and assay procedures, noting that different analytical methods may be required when a single procedure cannot provide sufficient discrimination [1]. HPLC purity therefore occupies one defined slot in a broader testing package, alongside identity and assay.

Fields, Outputs and Workflow Steps

A single HPLC purity percentage is interpreted together with the full analytical record. ICH Q2(R2) (2023) states that validation documentation includes representative data such as chromatograms, defined performance characteristics, and explicit criteria for the intended purpose; system suitability tests are described as an integral part of the procedure itself [1].

Minimum Verified Fields Required to Interpret an HPLC Purity Result

The following checklist reflects the documented requirements of ICH Q2(R2) (2023) [1]. Where a field is absent from a certificate of analysis (CoA), ask the supplier for it; together these fields make the result interpretable.

  • Chromatogram, the raw or processed trace showing peak separation, baseline, and retention times; the trace is what lets a reader assess the reported percentage.
  • Integrated peak areas, the numerical basis for the area-percentage calculation; the target peak area divided by total measured peak area under the stated conditions.
  • Method conditions, column type, mobile phase, gradient, flow rate, detector wavelength, and run time; purity figures are compared like-for-like, under the same method.
  • Validated reportable range, the concentration interval over which the method has demonstrated linearity, accuracy, and precision [1].
  • System suitability data, resolution, tailing factor, and theoretical plate count confirming the instrument performed within specification on the day of analysis [1].
  • Batch or lot identifier, the unique reference linking the result to a specific vial or shipment rather than a generic product.
  • Analysis date, required to assess whether the result falls within any stated stability window for the method or the compound.

A purity figure reads together with this supporting record, which is what lets a researcher or distributor confirm the number. Definitions for terms such as reportable range, system suitability, and area percentage are collected in the research peptide testing terms glossary for reference.

What the Evidence Can Establish

A validated HPLC purity procedure establishes, under a specified method, that the sample’s measured peak profile is sufficiently selective and precise for the intended purity determination, and that the reported area percentage is meaningful within the validated reportable range. ICH Q2(R2) (2023) states that a validated purity procedure demonstrates the absence of relevant interference and can use representative chromatograms, spiking experiments, forced degradation, or orthogonal comparison to confirm selectivity [1].

Purity and Impurity Quantification

Where the method is validated, HPLC supports quantitative purity determinations and establishes lower-range capability through quantitation limit (LOQ) and detection limit (LOD) work. ICH Q2(R2) (2023) requires that impurity tests demonstrate a quantitation limit at or below the reporting threshold, so that low-level impurities within the method’s selectivity window are captured [1].

Identity, Content and Contaminant Tests

Identity, absolute content and contaminant testing are separate evidence classes, each reported by its own procedure: molecular identity by mass spectrometry, absolute peptide content by the assay, sterility and endotoxin status by dedicated assays. ICH Q2(R2) (2023) explicitly separates purity and impurity testing from identity and assay procedures, noting that different analytical procedures may be required when one procedure does not provide sufficient discrimination [1]. A high area-percentage result reports the chromatographic profile under one method.

Researchers who need to confirm that a document belongs to the specific material being tested can verify a batch against its CoA before reading the purity figure.

What the Other Methods Report

Molecular identity, absolute peptide content, sterility and endotoxin status are each reported by a dedicated procedure. ICH Q2(R2) (2023) explicitly separates purity and impurity testing from identity and assay procedures, noting that different analytical procedures may be required when a single method does not provide sufficient discrimination between evidence classes [1].

Identity and Content

A high area-percentage result confirms the chromatographic profile under one specified method. The identity of the compound in the vial is confirmed by an orthogonal identity test such as mass spectrometry (MS), and the mass of compound in the vial by the assay, because HPLC measures detector response within the chromatogram [1].

Sterility and Endotoxin

Microbial contamination and endotoxin load are separate evidence classes with their own dedicated validated assays, reported alongside the purity figure on a complete certificate [1].

Method Selectivity

A purity percentage covers the impurities within the method’s selectivity window and detector response range. A compound that does not absorb at the detection wavelength, or that elutes outside the gradient, does not appear in the chromatogram, which is why orthogonal methods complete the impurity picture [1].

Researchers reviewing a supplier’s documentation can check that the CoA includes identity, assay and safety-relevant results alongside the HPLC figure. Veyvora’s research-peptide catalogue lists batch-level documentation for each product.

How to Match the Result to a Batch

A purity figure is read against the specific batch being accepted. ICH Q2(R2) (2023) requires that validation documentation use representative samples and that any method transfer or multi-site work include comparative analysis or partial revalidation to confirm the result applies to the material in question [1].

What to Check on the Certificate of Analysis

When reviewing a CoA, confirm that the following identifiers on the purity report match the physical batch:

  • Batch or lot number
  • Sample identifier recorded at the time of analysis
  • Analysis date
  • Method conditions: column, gradient, detection wavelength, and run time
  • Reportable range and any stated threshold or relative response factor
  • Laboratory name and, where available, accreditation reference

These identifiers are what tie the purity result to the vial; where one is absent or inconsistent, ask the supplier for it before treating the figure as batch-specific [1].

Source and Document Integrity

A purity result generated at one site applies to the batch it was generated for. ICH Q2(R2) (2023) states that transferred methods require documented comparative analysis of representative samples before the result is considered valid for the receiving batch [1]. Where a supplier provides results from two independent laboratories, confirm that both reports carry matching batch identifiers before treating either as corroborating evidence.

To confirm that a document belongs to the material being tested, use the verify a batch against its CoA workflow, which addresses the prerequisite question of document-to-material matching. Once batch integrity is confirmed, storage and stability guidance covers the separate handling requirements needed to protect material integrity after acceptance.

HPLC purity is one part of a broader analytical package. ICH Q2(R2) (2023) separates purity and impurity testing from identity procedures and assay or content determinations, noting that different analytical procedures may be required when a single method cannot provide sufficient discrimination [1]. Each evidence class has its own result on the certificate.

Identity, Content and Safety Tests

The four test categories that sit alongside HPLC purity in a complete CoA are:

  • Identity by an orthogonal method (typically LC-MS, meaning liquid chromatography coupled with mass spectrometry), which confirms molecular structure independently of peak-area separation
  • Assay or content determination, which establishes the actual quantity of analyte present rather than its relative detector response
  • Sterility testing, which addresses microbial contamination, outside the scope of chromatographic methods
  • Endotoxin assay, which quantifies pyrogen load using a validated biological or turbidimetric method [1]

Each requires its own validated procedure under ICH Q2(R2) (2023) [1].

Next Step

To review how these test categories appear together in a real batch document, use the verify a batch against its CoA workflow, and see how to read a CoA for a field-by-field guide to each certificate section. Definitions for adjacent analytical terms, including assay, LOD and LOQ, are available in the research peptide testing terms glossary. To see how a supplier’s testing package covers these criteria, review the batch-level certificates of analysis in Veyvora’s research-peptide catalogue.

Sources

[1] database.ich.org, https://database.ich.org/sites/default/files/ICH_Q2(R2)_Guideline_2023_1130.pdf [2] General Chapter <621> Chromatography, United States Pharmacopeial Convention (USP-NF), usp.org, https://www.usp.org/harmonization-standards/pdg/excipients/chromatography

© 2026 Veyvora. All rights reserved. For laboratory research use · store cold, 2–8 °C